FATE THERAPEUTICS INC's ticker is FATE and the CUSIP is 31189P102. A total of 189 filers reported holding FATE THERAPEUTICS INC in Q2 2023. The put-call ratio across all filers is 4.84 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2024 | $37,231 | -66.7% | 11,351 | -25.5% | 0.00% | – |
Q1 2024 | $111,766 | +113.0% | 15,227 | +8.5% | 0.00% | – |
Q4 2023 | $52,465 | +41.8% | 14,028 | -19.6% | 0.00% | – |
Q3 2023 | $36,998 | -55.3% | 17,452 | +0.4% | 0.00% | – |
Q2 2023 | $82,771 | -12.5% | 17,389 | +4.8% | 0.00% | – |
Q1 2023 | $94,557 | -53.1% | 16,589 | -17.0% | 0.00% | -100.0% |
Q4 2022 | $201,628 | -51.8% | 19,983 | +7.2% | 0.00% | -50.0% |
Q3 2022 | $418,000 | -7.1% | 18,636 | +2.3% | 0.00% | +100.0% |
Q2 2022 | $450,000 | -57.1% | 18,209 | -32.7% | 0.00% | -50.0% |
Q1 2022 | $1,049,000 | -46.0% | 27,053 | -18.5% | 0.00% | -50.0% |
Q4 2021 | $1,943,000 | +0.4% | 33,208 | +1.7% | 0.00% | -20.0% |
Q3 2021 | $1,935,000 | -40.8% | 32,646 | -13.3% | 0.01% | -50.0% |
Q2 2021 | $3,269,000 | +19.0% | 37,662 | +13.1% | 0.01% | +11.1% |
Q1 2021 | $2,746,000 | +3.0% | 33,302 | +13.5% | 0.01% | -10.0% |
Q4 2020 | $2,667,000 | +193.1% | 29,333 | +28.8% | 0.01% | +150.0% |
Q3 2020 | $910,000 | +26.7% | 22,774 | +8.8% | 0.00% | 0.0% |
Q2 2020 | $718,000 | +131.6% | 20,928 | +50.0% | 0.00% | +100.0% |
Q1 2020 | $310,000 | -35.6% | 13,954 | -43.2% | 0.00% | 0.0% |
Q4 2019 | $481,000 | +31.1% | 24,569 | +4.0% | 0.00% | 0.0% |
Q3 2019 | $367,000 | -29.0% | 23,627 | -7.2% | 0.00% | -33.3% |
Q2 2019 | $517,000 | +3.2% | 25,449 | -10.7% | 0.00% | 0.0% |
Q1 2019 | $501,000 | +38.0% | 28,513 | +0.9% | 0.00% | 0.0% |
Q4 2018 | $363,000 | – | 28,270 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
JOHNSON & JOHNSON | 3,379,064 | $197,709,000 | 22.51% |
Redmile Group, LLC | 12,957,222 | $758,127,000 | 17.24% |
Grosvenor Holdings, L.L.C. | 1,037,256 | $60,690,000 | 6.28% |
Casdin Capital, LLC | 3,400,000 | $198,934,000 | 5.61% |
Ally Bridge Group (NY) LLC | 270,000 | $15,798,000 | 5.52% |
DAFNA Capital Management LLC | 372,160 | $21,775,000 | 5.48% |
Tri Locum Partners LP | 142,032 | $8,310,000 | 3.27% |
Kynam Capital Management, LP | 95,561 | $5,591,000 | 2.99% |
Artal Group S.A. | 1,800,000 | $105,318,000 | 2.86% |
Bellevue Group AG | 3,775,736 | $220,918,000 | 2.28% |